Search results
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 1 day agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
Stocks Show Modest Gains As S&P 500 Hits All-Time High; Nvidia Reaches Two Milestones (Live Update)
Investor's Business Daily· 4 hours agoShares broke out of a cup-with-handle base with a 17.28 buy point. At 18.44 Nurix stock is slightly...
Community rallies around blind Yuba City teacher now battling leukemia
CBS News· 5 days agoMiranda Smith became a teacher after feeling inspired by her own teachers while growing up as a...
Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia
Digital Journal· 1 day agoVancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 17, 2024) - Investorideas.com, a go-to investing platform, releases the first of a two-part series looking at developments ...
IN8bio Decline After Favorable Leukemia Results Could Be Profit-Taking
Barrons.com· 4 days agoIN8bio shares fall 29% to $1.20 despite favorable data from a Phase 1 leukemia study. Mizuho...
Community leaders hosting fundraiser for 8-year-old leukemia patient
The Norman Transcript, Okla. via Yahoo News· 6 days agoNorman community members and sponsors will host a fundraising event this Saturday in hopes of alleviating the financial burden for a student who was recently diagnosed with a form of blood cancer ...
Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto
Market Watch· 4 days agoPublished: June 14, 2024 at 4:43 p.m. ETShareResizeBy Sabela OjeaAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers, ...
...POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)...
Morningstar· 4 days agoFood and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative ...
Atlanta Braves and Make-A-Wish grant 17-year-old's dream
WXIA-TV Atlanta· 8 hours agoAccording to the Braves, Stephen Grayson, 17, from Mississippi, has long aspired to meet his...
Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto
Morningstar· 4 days agoThe biotechnology company on Friday said the approval is aimed at adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic ...